Literature DB >> 15240660

C3a and C3b activation products of the third component of complement (C3) are critical for normal liver recovery after toxic injury.

Maciej M Markiewski1, Dimitrios Mastellos, Ruxandra Tudoran, Robert A DeAngelis, Christoph W Strey, Silvia Franchini, Rick A Wetsel, Anna Erdei, John D Lambris.   

Abstract

Although the complement system has been implicated in liver regeneration after toxic injury and partial hepatectomy, the mechanism or mechanisms through which it participates in these processes remains ill-defined. In this study, we demonstrate that complement activation products (C3a, C3b/iC3b) are generated in the serum of experimental mice after CCl(4) injection and that complement activation is required for normal liver regeneration. Decomplementation by cobra venom factor resulted in impaired entry of hepatocytes into S phase of the cell cycle. In addition, livers from C3-deficient (C3(-/-)) mice showed similarly impaired proliferation of hepatocytes, along with delayed kinetics of both hepatocyte hyperplasia and removal of injured liver parenchyma. Restoration of hepatocyte proliferative capabilities of C3(-/-) mice through C3a reconstitution, as well as the impaired regeneration of C3a receptor-deficient mice, demonstrated that C3a promotes liver cell proliferation via the C3a receptor. These findings, together with data showing two waves of complement activation, indicate that C3 activation is a pivotal mechanism for liver regeneration after CCl(4) injury, which fulfills multiple roles; C3a generated early after toxin injection is relevant during the priming of hepatocytes, whereas C3 activation at later times after CCl(4) treatment contributes to the clearance of injured tissue.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15240660     DOI: 10.4049/jimmunol.173.2.747

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  71 in total

1.  Detection and identification of potential biomarkers of breast cancer.

Authors:  Yuxia Fan; Jiachen Wang; Yang Yang; Qiuliang Liu; Yingzhong Fan; Jiekai Yu; Shu Zheng; Mengquan Li; Jiaxiang Wang
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-17       Impact factor: 4.553

Review 2.  Complement activation in the context of stem cells and tissue repair.

Authors:  Ingrid U Schraufstatter; Sophia K Khaldoyanidi; Richard G DiScipio
Journal:  World J Stem Cells       Date:  2015-09-26       Impact factor: 5.326

3.  Complement inhibition alleviates paraquat-induced acute lung injury.

Authors:  Shihui Sun; Hanbin Wang; Guangyu Zhao; Yingbo An; Yan Guo; Lanying Du; Hongbin Song; Fei Qiao; Hong Yu; Xiaohong Wu; Carl Atkinson; Shibo Jiang; Stephen Tomlinson; Yusen Zhou
Journal:  Am J Respir Cell Mol Biol       Date:  2011-03-18       Impact factor: 6.914

Review 4.  ALR and liver regeneration.

Authors:  Rafał Pawlowski; Jolanta Jura
Journal:  Mol Cell Biochem       Date:  2006-05-12       Impact factor: 3.396

5.  Complement activation in acetaminophen-induced liver injury in mice.

Authors:  Rohit Singhal; Patricia E Ganey; Robert A Roth
Journal:  J Pharmacol Exp Ther       Date:  2012-02-07       Impact factor: 4.030

Review 6.  Pathogenesis of alcoholic liver disease: interactions between parenchymal and non-parenchymal cells.

Authors:  Jessica I Cohen; Laura E Nagy
Journal:  J Dig Dis       Date:  2011-02       Impact factor: 2.325

7.  A pure population of lung alveolar epithelial type II cells derived from human embryonic stem cells.

Authors:  Dachun Wang; David L Haviland; Alan R Burns; Eva Zsigmond; Rick A Wetsel
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-02       Impact factor: 11.205

8.  Evidence for non-traditional activation of complement factor C3 during murine liver regeneration.

Authors:  Amelia Clark; Alexander Weymann; Eric Hartman; Yumirle Turmelle; Michael Carroll; Joshua M Thurman; V Michael Holers; Dennis E Hourcade; David A Rudnick
Journal:  Mol Immunol       Date:  2008-05-01       Impact factor: 4.407

9.  The complement component C3a fragment is a potential biomarker for hepatitis C virus-related hepatocellular carcinoma.

Authors:  Shuji Kanmura; Hirofumi Uto; Yuko Sato; Koutarou Kumagai; Fumisato Sasaki; Akihiro Moriuchi; Makoto Oketani; Akio Ido; Kenji Nagata; Katsuhiro Hayashi; Sherri O Stuver; Hirohito Tsubouchi
Journal:  J Gastroenterol       Date:  2009-12-09       Impact factor: 7.527

10.  Complement component 3 is necessary to preserve myocardium and myocardial function in chronic myocardial infarction.

Authors:  Marcin Wysoczynski; Mitesh Solanki; Sylwia Borkowska; Patrick van Hoose; Kenneth R Brittian; Sumanth D Prabhu; Mariusz Z Ratajczak; Gregg Rokosh
Journal:  Stem Cells       Date:  2014-09       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.